Targeted inhibition of eIF5Ahpu suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer

被引:8
|
作者
Zeng, Jincheng [1 ,2 ]
Ye, Ziyu [1 ,2 ]
Shi, Shihong [1 ]
Liang, Yanfang [3 ]
Meng, Qingyu [1 ]
Zhang, Qunzhou [1 ]
Le, Anh D. [1 ,4 ]
机构
[1] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg & Pharmacol, Philadelphia, PA 19104 USA
[2] Guangdong Med Univ, Dongguan Key Lab Med Bioact Mol Dev & Translat Res, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan 523808, Peoples R China
[3] Jinan Univ, Dongguan Hosp, Binhaiwan Cent Hosp Dongguan, Dept Pathol, Dongguan 523905, Peoples R China
[4] Univ Penn, Penn Med Hosp, Perelman Ctr Adv Med, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19104 USA
关键词
SQUAMOUS-CELL CARCINOMA; NECK-CANCER; MESENCHYMAL TRANSITION; OROPHARYNGEAL CANCER; HEAD; INITIATION; RECURRENT; HYPUSINE; THERAPY; PROGRESSION;
D O I
10.1038/s41419-023-06109-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Eukaryotic initiation factor 5A2 (eIF5A2) is overexpressed in many types of cancer, and spermidine-mediated eIF5A hypusination (eIF5A(hpu)) appears to be essential to most of eIF5A's biological functions, including its important role in regulating cancer cell proliferation, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) properties as well as immune cell functions. Here we investigated the role of eIF5A(hpu) in the growth of oral squamous cell carcinoma cells (OSCCs) and OSCC-induced polarization of M2-like tumor-associated macrophages (TAMs). TCGA dataset analysis revealed an overall upregulation in the mRNA expression of eIF5A2 and several key enzymes involved in polyamine (PA) metabolism in HNSCC, which was confirmed by Western blot and IHC studies. Blocking eIF5A(hpu) by GC-7 but not the upstream key enzyme activities of PA metabolism, remarkably inhibited cell proliferation and the expression of EMT- and CSC-related genes in OSCC cells. In addition, blocking eIF5A(hpu) robustly inhibited OSCC-induced M2-like TAM polarization in vitro. More Importantly, blocking eIF5A(hpu) dramatically retarded tumor growth and infiltration/polarization of M2-like TAM in a syngeneic orthotopic murine tongue SCC model. Thus, eIF5A(hpu) plays dual functions in regulating tumor cell growth and polarization of M2-TAMs in OSCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
    Shujing Wang
    Jingrui Wang
    Zhiqiang Chen
    Jiamin Luo
    Wei Guo
    Lingling Sun
    Lizhu Lin
    npj Precision Oncology, 8
  • [32] Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated Macrophages
    Mitsuhashi, Atsushi
    Goto, Hisatsugu
    Kuramoto, Takuya
    Tabata, Sho
    Yukishige, Sawaka
    Abe, Shinji
    Hanibuchi, Masaki
    Kakiuchi, Soji
    Saijo, Atsuro
    Aono, Yoshinori
    Uehara, Hisanori
    Yano, Seiji
    Ledford, Julie G.
    Sone, Saburo
    Nishioka, Yasuhiko
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (05): : 1843 - 1853
  • [33] Hydroxygenkwanin suppresses peritoneal metastasis in colorectal cancer by modulating tumor-associated macrophages polarization
    Xun, Jing
    Hu, Zhibo
    Wang, Meilin
    Jiang, Xiaolin
    Liu, Bin
    Han, Yingdi
    Gao, Ruifang
    Wu, Xueliang
    Zhang, Aimin
    Yang, Shimin
    Wang, Ximo
    Yu, Xiangyang
    Zhang, Qi
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 396
  • [34] Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
    Laoui, Damya
    Van Overmeire, Eva
    Di Conza, Giusy
    Aldeni, Chiara
    Keirsse, Jiri
    Morias, Yannick
    Movahedi, Kiavash
    Houbracken, Isabelle
    Schouppe, Elio
    Elkrim, Yvon
    Karroum, Oussama
    Jordan, Benedicte
    Carmeliet, Peter
    Gysemans, Conny
    DeBaetselier, Patrick
    Mazzone, Massimiliano
    Van Ginderachter, Jo A.
    CANCER RESEARCH, 2014, 74 (01) : 24 - 30
  • [35] Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages
    Zhang, Zhihao
    Zhang, Jingwen
    He, Ping
    Han, Jingjing
    Sun, Changyu
    MOLECULAR IMMUNOLOGY, 2020, 122 : 13 - 20
  • [36] miR-498 inhibits autophagy and M2-like polarization of tumor-associated macrophages in esophageal cancer via MDM2/ATF3
    Li, Dezhi
    Yan, Min
    Sun, Fengfei
    Song, Junmei
    Hu, Xingsheng
    Yu, Sijia
    Tang, Lina
    Deng, Shishan
    EPIGENOMICS, 2021, 13 (13) : 1013 - 1030
  • [37] Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth
    Takimoto, Yumi
    Tsubamoto, Hiroshi
    Taniguchi, Roze
    Sakata, Kazuko
    Takada, Yoko
    Adachi, Jun
    Tomonaga, Takeshi
    Ueda, Tomoko
    Nakagawa, Kohei
    Narita, Sachiyo
    Wakimoto, Yu
    Shibahara, Hiroaki
    ANTICANCER RESEARCH, 2023, 43 (02) : 569 - 580
  • [38] Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma
    Yin, Ji-Zhong
    Shi, Xiao-Qian
    Wang, Ming-Dong
    Du, He
    Zhao, Xue-Wei
    Li, Bing
    Yang, Meng-Hang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [39] Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor-associated macrophages
    Gao, Xuehan
    Long, Runying
    Qin, Ming
    Zhu, Wenfang
    Wei, Linna
    Dong, Pinzhi
    Chen, Jin
    Luo, Junmin
    Feng, Jihong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 53 (01)
  • [40] Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
    Di Martile, Marta
    Farini, Valentina
    Consonni, Francesca Maria
    Trisciuoglio, Daniela
    Desideri, Marianna
    Valentini, Elisabetta
    D'Aguanno, Simona
    Tupone, Maria Grazia
    Buglioni, Simonetta
    Ercolani, Cristiana
    Gallo, Enzo
    Amadio, Bruno
    Terrenato, Irene
    Foddai, Maria Laura
    Sica, Antonio
    Del Bufalo, Donatella
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)